Article
Lipid-lowering fibrates extend C. elegans lifespan in a NHR-49/PPARalpha-dependent manner.
Aging - 1 Apr 2013
Brandstädt Sven, Schmeisser Kathrin, Zarse Kim, Ristow Michael
Abstract excerpt
Compounds that delay aging in model organisms may be of significant interest to anti-aging medicine, since these substances potentially provide pharmaceutical approaches to promote healthy lifespan in humans. We here aimed to test whether pharmaceutical concentrations of three fibrates, pharmacologically established serum lipid-lowering drugs and ligands of the nuclear receptor PPARalpha in mammals, are capable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
